Experiment: 2MSG

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
2	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
3	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
4	NCO	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
5	INEPT	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
6	NCACX	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
7	NCOCX	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
8	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
9	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
10	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
11	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
12	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
13	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
14	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
15	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	850
3	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	10
Representative Model	1 (minimized average structure)

Additional NMR Experimental Information
Details	three different labeled samples Ubiquitin-unif [13C-15N] uniformly labeled Ubiquitin-1glc [13C-15N]-1glucose labeled Ubiquitin-2glu [13C-15N]-2glucose labeled

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	X-PLOR NIH	2.36	Bruker Biospin
2	chemical shift assignment	X-PLOR NIH	2.36	Bruker Biospin
3	data analysis	X-PLOR NIH	2.36	Bruker Biospin
4	refinement	X-PLOR NIH	2.36	Bruker Biospin
5	structure validation	X-PLOR NIH	2.36	Bruker Biospin
6	processing	X-PLOR NIH	2.36	Goddard
7	chemical shift assignment	X-PLOR NIH	2.36	Goddard
8	data analysis	X-PLOR NIH	2.36	Goddard
9	refinement	X-PLOR NIH	2.36	Goddard
10	structure validation	X-PLOR NIH	2.36	Goddard
11	processing	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
12	chemical shift assignment	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
13	data analysis	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
14	refinement	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
15	structure validation	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
16	processing	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
17	chemical shift assignment	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
18	data analysis	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
19	refinement	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
20	structure validation	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
21	processing	X-PLOR NIH	2.36	Bhattacharya and Montelione
22	chemical shift assignment	X-PLOR NIH	2.36	Bhattacharya and Montelione
23	data analysis	X-PLOR NIH	2.36	Bhattacharya and Montelione
24	refinement	X-PLOR NIH	2.36	Bhattacharya and Montelione
25	structure validation	X-PLOR NIH	2.36	Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

2MSG | pdb_00002msg

Solid-state NMR structure of ubiquitin

Prepare Data

Validate Data

Deposit Data

Help and Resources

.id_divider{ color: #ccc; padding: 0 10px 0 10px; } .extended_id_info{ color: #ccc; font-size: 18px; position: relative; top: -10px; left: 4px; } 2MSG | pdb_00002msg

Solid-state NMR structure of ubiquitin

2MSG | pdb_00002msg